The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
05-Aug-14
$1.3 billion
Target:
Siemens Health Services
Acquiror:
Cerner Corporation
Advised Cerner Corporation, a leader in healthcare information services, on the acquisition of the assets of Siemens Aktiengesellschaft’s healthcare information technology business unit, Siemens Health Services, for $1.3 billion in cash.
28-Jul-14
$90 million
Target:
Clinuvel Pharmaceuticals Limited
Acquiror:
Retrophin, Inc.
Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases
13-May-14
$80 million
Target:
Publications International, Ltd. Children’s Division
Acquiror:
Jiangsu Phoenix Publishing and Media Corporation Limited
Advised Publications International, a leading consumer book publisher, on the sale of its Children’s Division to Jiangsu Phoenix Publishing and Media Corporation Limited
08-Apr-14
$NA
Target:
ARTnews
Acquiror:
Skate Capital Corp.
Advised ARTnews, the world's oldest and most widely circulated art magazine, on its sale to Skate Capital Corp., a private art and media industry investment vehicle
18-Feb-14
$25.1 billion
Target:
Forest Laboratories Inc.
Acquiror:
Actavis plc
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
18-Dec-13
$NA
Target:
Global Television
Acquiror:
NEP Group Inc.
Advised Catalyst Investment Managers on the sale of its portfolio company Global Television, Australia’s largest provider of outsourced broadcasting and video production services, to NEP Inc., a leading provider of total broadcast solutions in the US, UK and Brazil. NEP is majority-owned by private funds managed by Crestview Partners
18-Dec-13
$141 million
Target:
Open Colleges Australia Pty Ltd
Acquiror:
Apollo Education Group, Inc.
Advised Open Colleges, Australia’s leading privately owned online provider in the high-growth vocational education and training sector, on the sale of a 70% stake (plus exit arrangements for the balance) to Apollo Education Group, Inc., one of North America’s largest private education providers
31-May-13
$500 million
Target:
iSelect (30% shareholding)
Acquiror:
Ninemsn (T/A Mi9)
Advised Mi9, a joint venture between Microsoft and Nine Entertainment Co, and one of Australia’s leading digital media companies, on the sale of its 30% holding in iSelect, a leading Australian online-driven comparison service, as part of the Initial Public Offering of iSelect
20-May-13
$8.5 billion
Target:
Warner Chilcott, plc
Acquiror:
Actavis, Inc.
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
15-Jan-13
$NA
Target:
Broadcast Rights for V8 Supercars
Acquiror:
Seven Network
Advised Archer Capital, a leading Australian private equity firm, and its portfolio company V8 Supercars Australia, on the sale of the Australian FTA television broadcasting rights for V8 Supercars to Seven, a leading Free to Air broadcaster in Australia
01-Nov-12
$180 million
Target:
SKY Network Television Limited
Advised Todd Corporation, a major New Zealand family office, on the divestment of its 11.1% holding in SKY Network Television Limited, New Zealand’s leading provider of pay television services
08-Oct-12
$NA
Target:
Phaidon Press Limited
Acquiror:
Leon D. Black family
Advised Phaidon Press Limited (“Phaidon”) and its owner, Richard Schlagman, on the sale of the company to the family of Leon Black. Founded in 1923, Phaidon is a leading branded publishing and media company focused on the visual arts, culture and lifestyle sectors
02-Sep-12
$285 million
Target:
DMG Radio Australia, a subsidiary of Daily Mail and Guardian Trust Plc
Acquiror:
Illyria Pty
Advised Daily Mail and Guardian Trust plc (DMGT), on the sale of its remaining 50% interest in its Radio business in Australia to Illyria Pty, a private investment company of Lachlan Murdoch. The Radio operations comprise two national music networks in Australia
21-Aug-12
$1.1 billion
Target:
Broadcast Rights for the National Rugby League
Acquiror:
Nine Network / Fox Sports
Advised the Australian Rugby League Commission on the sale of the Australian television broadcasting rights for the National Rugby League to Nine, a leading Free to Air broadcaster and Fox Sports, Australia’s largest pay TV broadcaster (partially owned by News Limited)
12-Jul-12
$5.0 billion
Target:
Aegis Group plc
Acquiror:
Dentsu Inc.
Advised Aegis Group plc, a leading global media and digital communications agency, on its sale to Dentsu Inc., the leading advertising group in Asia
21-May-12
$NA
Target:
Robbins-Gioia Inc.
Acquiror:
Private Investors
Advised Informa plc on the sale of its subsidiary, Robbins-Gioia Inc., to a group of private investors
21-Nov-11
$689 million
Target:
iNova Pharmaceuticals
Acquiror:
Valeant Pharmaceuticals
Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals
27-Jul-11
$850 million
Target:
The Synovate Group
Acquiror:
Ipsos S.A.
Advised Aegis Group plc on the sale of The Synovate Group, a leading global provider of custom market research, to Ipsos S.A.
15-Dec-10
$12.9 billion
Target:
Alcon, Inc.
Acquiror:
Novartis AG
Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company
13-Dec-10
$256 million
Target:
Maxinutrition Group Holdings Limited
Acquiror:
GlaxoSmithKline Plc
Advised GlaxoSmithKline Plc, the UK listed international pharmaceutical and consumer company, on its acquisition of Maxinutrition Group Holdings Limited, a UK based sports nutrition business, from Darwin Private Equity
26-Nov-10
$118 million
Target:
Healthcare Australia
Acquiror:
Healthcare Locums
Advised CHAMP Private Equity on the sale of Healthcare Australia, a leading provider of nursing agency staff to public and private health institutions in Australia, to Healthcare Locums, a healthcare recruitment agency based in the UK
21-Sep-10
$234 million
Target:
Taro Pharmaceutical Industries
Acquiror:
Sun Pharmaceutical Industries Ltd.
Advised Sun Pharmaceutical Industries Ltd., the largest Indian pharmaceutical company by market capitalization, on its acquisition of a majority interest in Israeli based Taro Pharmaceutical Industries, a multinational generics pharmaceutical company
29-Jul-10
$328 million
Target:
Mitchell Communication Group Limited
Acquiror:
Aegis Group plc
Advised Aegis Group plc on its acquisition of Mitchell Communication Group Limited, Australia’s leading independent media buyer
01-Jul-10
$NA
Target:
Media Monitors
Acquiror:
Quadrant Private Equity
Advised Media Monitors, the leading media intelligence company in Asia-Pacific, on its sale to Quadrant Private Equity
04-Jun-10
$232 million
Target:
Manx Telecom
Acquiror:
HgCapital
Advised HgCapital, a leading European private equity investor, on its acquisition of Manx Telecom, the Isle of Man's main telecommunications and internet provider and a subsidiary of Telefónica S.A.